Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
BioFluidica LiquidScan harnesses the power of microfluidics
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
Subscribe To Our Newsletter & Stay Updated